Literature DB >> 25688758

New proline-rich oligopeptides from the venom of African adders: Insights into the hypotensive effect of the venoms.

Roberto T Kodama1, Daniela Cajado-Carvalho1, Alexandre K Kuniyoshi1, Eduardo S Kitano2, Alexandre K Tashima3, Barbara F Barna4, Ana Carolina Takakura5, Solange M T Serrano2, Wilmar Dias-Da-Silva1, Denise V Tambourgi1, Fernanda V Portaro6.   

Abstract

BACKGROUND: The snakes from the Bitis genus are some of the most medically important venomous snakes in sub Saharan Africa, however little is known about the composition and effects of these snake venom peptides. Considering that the victims with Bitis genus snakes have exacerbate hypotension and cardiovascular disorders, we investigated here the presence of angiotensin-converting enzyme modulators on four different species of venoms.
METHODS: The peptide fractions from Bitis gabonica gabonica, Bitis nasicornis, Bitis gabonica rhinoceros and Bitis arietans which showed inhibitory activity on angiotensin-converting enzyme were subjected to mass spectrometry analysis. Eight proline-rich peptides were synthetized and their potencies were evaluated in vitro and in vivo.
RESULTS: The MS analysis resulted in over 150 sequences, out of which 32 are new proline-rich oligopeptides, and eight were selected for syntheses. For some peptides, inhibition assays showed inhibitory potentials of cleavage of angiotensin I ten times greater when compared to bradykinin. In vivo tests showed that all peptides decreased mean arterial pressure, followed by tachycardia in 6 out of 8 of the tests.
CONCLUSION: We describe here some new and already known proline-rich peptides, also known as bradykinin-potentiating peptides. Four synthetic peptides indicated a preferential inhibition of angiotensin-converting enzyme C-domain. In vivo studies show that the proline-rich oligopeptides are hypotensive molecules. GENERAL SIGNIFICANCE: Although proline-rich oligopeptides are known molecules, we present here 32 new sequences that are inhibitors of the angiotensin-converting enzyme and consistent with the symptoms of the victims of Bitis spp, who display severe hypotension.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiotensin-converting enzyme (ACE); Bitis; Bradykinin-potentiating peptide (BPP); Hypotension; Proline-rich oligopeptide (PRO); Venom

Mesh:

Substances:

Year:  2015        PMID: 25688758     DOI: 10.1016/j.bbagen.2015.02.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  Strategies in 'snake venomics' aiming at an integrative view of compositional, functional, and immunological characteristics of venoms.

Authors:  Bruno Lomonte; Juan J Calvete
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-04-28

2.  Kn-Ba: a novel serine protease isolated from Bitis arietans snake venom with fibrinogenolytic and kinin-releasing activities.

Authors:  Ângela Alice Amadeu Megale; Fábio Carlos Magnoli; Alexandre Kazuo Kuniyoshi; Leo Kei Iwai; Denise V Tambourgi; Fernanda C V Portaro; Wilmar Dias da Silva
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-12-13

3.  Isolation and characterization of Bradykinin potentiating peptides from Agkistrodon bilineatus venom.

Authors:  Aisha Munawar; Anum Zahid; Amr Negm; Ahmed Akrem; Patrick Spencer; Christian Betzel
Journal:  Proteome Sci       Date:  2016-01-14       Impact factor: 2.480

Review 4.  ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.

Authors:  Lizelle Lubbe; Gyles E Cozier; Delia Oosthuizen; K Ravi Acharya; Edward D Sturrock
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

5.  Bitis arietans Snake Venom and Kn-Ba, a Snake Venom Serine Protease, Induce the Production of Inflammatory Mediators in THP-1 Macrophages.

Authors:  Ângela Alice Amadeu Megale; Fabio Carlos Magnoli; Felipe Raimondi Guidolin; Kemily Stephanie Godoi; Fernanda Calheta Vieira Portaro; Wilmar Dias-da-Silva
Journal:  Toxins (Basel)       Date:  2021-12-16       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.